Global Pen Needles Supply, Demand and Key Producers, 2026-2032
Description
The global Pen Needles market size is expected to reach $ 2288 million by 2032, rising at a market growth of 6.4% CAGR during the forecast period (2026-2032).
A pen needle is a disposable, minimally invasive injection device designed to be used with insulin pens, GLP-1 receptor agonist pens, recombinant biologics, and other injectable drug delivery systems for the treatment of chronic conditions such as diabetes, obesity, and rheumatoid arthritis. It consists of a needle tube, cap, inner protective guard, and threaded hub, typically manufactured from precision stainless steel with advanced laser sharpening and lubrication technologies to reduce penetration resistance, providing a more precise, comfortable, and safe injection experience. With the rising prevalence of diabetes and obesity, as well as increasing demand for self-administration and home-based therapies, pen needles have become an essential consumable in chronic disease management. The market is not only driven by insulin growth but also accelerated by the surge in GLP-1 and biologics injections, making it a strategic focus for leading medical device companies.In 2024, global pen needle production reached approximately 11733 million units, with an average global market price of around US$ 118.1 per k unit.
The pen needle market is experiencing rapid growth, fueled by surging global demand for chronic disease treatments, particularly for diabetes and obesity. According to the International Diabetes Federation (IDF), the number of people with diabetes surpassed 540 million in 2024 and is expected to reach nearly 640 million by 2030. The widespread adoption of GLP-1 weight-loss drugs is expanding the non-insulin injection market, positioning pen needles as a high-growth category for pharmaceutical and medical device companies. Policies in many countries encourage home self-injection to alleviate healthcare system burdens. Pharmaceutical companies are driving innovations in drug delivery, and pen needle technology is evolving accordingly, from ultra-thin needle tips and painless injection designs to advanced safety features, creating a dynamic market with fast-paced product upgradeDespite its promising outlook, the pen needle industry faces challenges such as raw material price volatility, product homogenization, and regulatory hurdles in international trade. The cost of high-precision stainless steel tubing is influenced by fluctuations in global steel prices and advanced manufacturing processes. Limited differentiation in product design and specifications has led to intense price competition, squeezing margins. Developed markets enforce increasingly strict quality standards, regulatory approvals, and procurement policies, raising barriers to entry and compliance costs. Additionally, the growing reliance on a few pharmaceutical giants dominating GLP-1 and biologics markets creates a relatively stable yet imbalanced competitive landscape. Future demand for pen needles will emphasize personalization, comfort, and value-added features. With the expansion of long-acting insulin, GLP-1 therapies, and biologic injections, the market is diversifying beyond diabetes into obesity management, autoimmune diseases, and rare disorders. Patient experience is a core driver, spurring the development of thinner, shorter needles with silicone lubrication and safety-lock mechanisms to reduce injection anxiety. Digital health solutions and smart drug management systems are also integrating with pen needles, enabling “drug-device ecosystem” offerings. As healthcare systems prioritize home care and self-administration, the high-end pen needle market is poised for growth, with opportunities for global expansion through innovation and strong branding.
Key raw materials for pen needles include medical-grade stainless steel tubing, polypropylene (PP) for needle hubs and caps, and medical silicone lubricants. The precision tubing market is dominated by a few suppliers, such as Nippon Steel & Sumikin Precision, Sandvik, and Kobe Steel, which specialize in high-precision cold-drawing and surface treatment. Plastic materials are mainly supplied by Sinopec, SABIC, and LG Chem, ensuring relatively stable availability, while silicone lubricants are sourced from companies like Dow Corning and Shin-Etsu Chemical. Overall, the pen needle supply chain is highly concentrated, with stainless steel price fluctuations being the primary cost factor; leading manufacturers mitigate risks through long-term procurement contracts and in-house needle tubing production.
This report studies the global Pen Needles production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Pen Needles and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Pen Needles that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Pen Needles total production and demand, 2021-2032, (M Units)
Global Pen Needles total production value, 2021-2032, (USD Million)
Global Pen Needles production by region & country, production, value, CAGR, 2021-2032, (USD Million) & (M Units), (based on production site)
Global Pen Needles consumption by region & country, CAGR, 2021-2032 & (M Units)
U.S. VS China: Pen Needles domestic production, consumption, key domestic manufacturers and share
Global Pen Needles production by manufacturer, production, price, value and market share 2021-2026, (USD Million) & (M Units)
Global Pen Needles production by Type, production, value, CAGR, 2021-2032, (USD Million) & (M Units)
Global Pen Needles production by Application, production, value, CAGR, 2021-2032, (USD Million) & (M Units)
This report profiles key players in the global Pen Needles market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Embecta, MTD Group, Novo Nordisk, B. Braun, Terumo, Owen Mumford, Bepu Medical, KDL Medical, Ulticare, Promisemed, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Pen Needles market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (M Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global Pen Needles Market, By Region:
United States
China
Europe
Japan
South Korea
ASEAN
India
Rest of World
Global Pen Needles Market, Segmentation by Type:
Standard Pen Needles
Safety Pen Needles
Global Pen Needles Market, Segmentation by Application:
Home Use
Medical Institutions
Others
Companies Profiled:
Embecta
MTD Group
Novo Nordisk
B. Braun
Terumo
Owen Mumford
Bepu Medical
KDL Medical
Ulticare
Promisemed
Tianjin Huahong
Anhui Hongyu Wuzhou Medical
Jiangxi Hongda Medical
Suzhou Shali Medical
Jiangsu Jichun Medical Equipment
Key Questions Answered:
1. How big is the global Pen Needles market?
2. What is the demand of the global Pen Needles market?
3. What is the year over year growth of the global Pen Needles market?
4. What is the production and production value of the global Pen Needles market?
5. Who are the key producers in the global Pen Needles market?
6. What are the growth factors driving the market demand?
A pen needle is a disposable, minimally invasive injection device designed to be used with insulin pens, GLP-1 receptor agonist pens, recombinant biologics, and other injectable drug delivery systems for the treatment of chronic conditions such as diabetes, obesity, and rheumatoid arthritis. It consists of a needle tube, cap, inner protective guard, and threaded hub, typically manufactured from precision stainless steel with advanced laser sharpening and lubrication technologies to reduce penetration resistance, providing a more precise, comfortable, and safe injection experience. With the rising prevalence of diabetes and obesity, as well as increasing demand for self-administration and home-based therapies, pen needles have become an essential consumable in chronic disease management. The market is not only driven by insulin growth but also accelerated by the surge in GLP-1 and biologics injections, making it a strategic focus for leading medical device companies.In 2024, global pen needle production reached approximately 11733 million units, with an average global market price of around US$ 118.1 per k unit.
The pen needle market is experiencing rapid growth, fueled by surging global demand for chronic disease treatments, particularly for diabetes and obesity. According to the International Diabetes Federation (IDF), the number of people with diabetes surpassed 540 million in 2024 and is expected to reach nearly 640 million by 2030. The widespread adoption of GLP-1 weight-loss drugs is expanding the non-insulin injection market, positioning pen needles as a high-growth category for pharmaceutical and medical device companies. Policies in many countries encourage home self-injection to alleviate healthcare system burdens. Pharmaceutical companies are driving innovations in drug delivery, and pen needle technology is evolving accordingly, from ultra-thin needle tips and painless injection designs to advanced safety features, creating a dynamic market with fast-paced product upgradeDespite its promising outlook, the pen needle industry faces challenges such as raw material price volatility, product homogenization, and regulatory hurdles in international trade. The cost of high-precision stainless steel tubing is influenced by fluctuations in global steel prices and advanced manufacturing processes. Limited differentiation in product design and specifications has led to intense price competition, squeezing margins. Developed markets enforce increasingly strict quality standards, regulatory approvals, and procurement policies, raising barriers to entry and compliance costs. Additionally, the growing reliance on a few pharmaceutical giants dominating GLP-1 and biologics markets creates a relatively stable yet imbalanced competitive landscape. Future demand for pen needles will emphasize personalization, comfort, and value-added features. With the expansion of long-acting insulin, GLP-1 therapies, and biologic injections, the market is diversifying beyond diabetes into obesity management, autoimmune diseases, and rare disorders. Patient experience is a core driver, spurring the development of thinner, shorter needles with silicone lubrication and safety-lock mechanisms to reduce injection anxiety. Digital health solutions and smart drug management systems are also integrating with pen needles, enabling “drug-device ecosystem” offerings. As healthcare systems prioritize home care and self-administration, the high-end pen needle market is poised for growth, with opportunities for global expansion through innovation and strong branding.
Key raw materials for pen needles include medical-grade stainless steel tubing, polypropylene (PP) for needle hubs and caps, and medical silicone lubricants. The precision tubing market is dominated by a few suppliers, such as Nippon Steel & Sumikin Precision, Sandvik, and Kobe Steel, which specialize in high-precision cold-drawing and surface treatment. Plastic materials are mainly supplied by Sinopec, SABIC, and LG Chem, ensuring relatively stable availability, while silicone lubricants are sourced from companies like Dow Corning and Shin-Etsu Chemical. Overall, the pen needle supply chain is highly concentrated, with stainless steel price fluctuations being the primary cost factor; leading manufacturers mitigate risks through long-term procurement contracts and in-house needle tubing production.
This report studies the global Pen Needles production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Pen Needles and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Pen Needles that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Pen Needles total production and demand, 2021-2032, (M Units)
Global Pen Needles total production value, 2021-2032, (USD Million)
Global Pen Needles production by region & country, production, value, CAGR, 2021-2032, (USD Million) & (M Units), (based on production site)
Global Pen Needles consumption by region & country, CAGR, 2021-2032 & (M Units)
U.S. VS China: Pen Needles domestic production, consumption, key domestic manufacturers and share
Global Pen Needles production by manufacturer, production, price, value and market share 2021-2026, (USD Million) & (M Units)
Global Pen Needles production by Type, production, value, CAGR, 2021-2032, (USD Million) & (M Units)
Global Pen Needles production by Application, production, value, CAGR, 2021-2032, (USD Million) & (M Units)
This report profiles key players in the global Pen Needles market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Embecta, MTD Group, Novo Nordisk, B. Braun, Terumo, Owen Mumford, Bepu Medical, KDL Medical, Ulticare, Promisemed, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Pen Needles market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (M Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global Pen Needles Market, By Region:
United States
China
Europe
Japan
South Korea
ASEAN
India
Rest of World
Global Pen Needles Market, Segmentation by Type:
Standard Pen Needles
Safety Pen Needles
Global Pen Needles Market, Segmentation by Application:
Home Use
Medical Institutions
Others
Companies Profiled:
Embecta
MTD Group
Novo Nordisk
B. Braun
Terumo
Owen Mumford
Bepu Medical
KDL Medical
Ulticare
Promisemed
Tianjin Huahong
Anhui Hongyu Wuzhou Medical
Jiangxi Hongda Medical
Suzhou Shali Medical
Jiangsu Jichun Medical Equipment
Key Questions Answered:
1. How big is the global Pen Needles market?
2. What is the demand of the global Pen Needles market?
3. What is the year over year growth of the global Pen Needles market?
4. What is the production and production value of the global Pen Needles market?
5. Who are the key producers in the global Pen Needles market?
6. What are the growth factors driving the market demand?
Table of Contents
123 Pages
- 1 Supply Summary
- 2 Demand Summary
- 3 World Manufacturers Competitive Analysis
- 4 United States VS China VS Rest of the World
- 5 Market Analysis by Type
- 6 Market Analysis by Application
- 7 Company Profiles
- 8 Industry Chain Analysis
- 9 Research Findings and Conclusion
- 10 Appendix
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
